INTEGRATED BIOPHARMA INC financial data

Symbol
INBP on OTC
Location
Hillside, NJ
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 11 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 426% % 45%
Quick Ratio 218% % 20%
Debt-to-equity 23% % -36%
Return On Equity -1% % -121%
Return On Assets -0.83% % -123%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,059,610 shares 2.5%
Common Stock, Shares, Outstanding 31,094,510 shares 2.6%
Entity Public Float $3,111,877 USD -7.6%
Common Stock, Value, Issued $61,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 31,059,610 shares 2.9%
Weighted Average Number of Shares Outstanding, Diluted 31,059,610 shares -0.78%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) $577,000 USD -60%
Nonoperating Income (Expense) $40,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $695,000 USD -52%
Income Tax Expense (Benefit) $901,000 USD 71%
Net Income (Loss) Attributable to Parent $206,000 USD -122%
Earnings Per Share, Basic -0.01 USD/shares -150%
Earnings Per Share, Diluted -0.02 USD/shares -167%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,314,000 USD 116%
Accounts Receivable, after Allowance for Credit Loss, Current $3,592,000 USD -15%
Inventory, Net $8,363,000 USD -24%
Other Assets, Current $550,000 USD 38%
Assets, Current $17,819,000 USD -1.8%
Deferred Income Tax Assets, Net $3,388,000 USD -22%
Property, Plant and Equipment, Net $1,765,000 USD -0.34%
Operating Lease, Right-of-Use Asset $366,000 USD -72%
Assets $23,547,000 USD -8.2%
Accounts Payable, Current $2,144,000 USD -24%
Liabilities, Current $3,541,000 USD -36%
Operating Lease, Liability, Noncurrent $145,000 USD -60%
Liabilities $3,778,000 USD -36%
Retained Earnings (Accumulated Deficit) $32,058,000 USD -0.65%
Stockholders' Equity Attributable to Parent $19,769,000 USD 0.21%
Liabilities and Equity $23,547,000 USD -8.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,301,000 USD 98%
Net Cash Provided by (Used in) Financing Activities $11,000 USD -57%
Net Cash Provided by (Used in) Investing Activities $173,000 USD -209%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 31,094,510 shares 2.5%
Common Stock, Par or Stated Value Per Share 0.002 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,117,000 USD 88%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,000 USD -83%
Deferred Tax Assets, Valuation Allowance $1,776,000 USD 40%
Operating Lease, Liability $1,323,000 USD
Depreciation $305,000 USD -4.7%
Payments to Acquire Property, Plant, and Equipment $173,000 USD 209%
Lessee, Operating Lease, Liability, to be Paid $1,400,000 USD
Property, Plant and Equipment, Gross $10,110,000 USD 2.4%
Operating Lease, Liability, Current $221,000 USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year Two $169,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $661,000 USD
Deferred Income Tax Expense (Benefit) $68,000 USD -65%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $64,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $4,367,000 USD -13%
Deferred Federal Income Tax Expense (Benefit) $1,247,000 USD 190%
Operating Lease, Payments $254,000 USD -4.5%
Additional Paid in Capital $51,864,000 USD 0.48%
Depreciation, Depletion and Amortization $77,000 USD -9.4%
Deferred State and Local Income Tax Expense (Benefit) $140,000 USD -312%
Interest Expense $52,000 USD 0%